Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection
Clinical trial NCT06510582 · RECRUITING
Trial details
- NCT number
- NCT06510582
- Sponsor
- The Cooper Health System
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2028-06-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.